Asahi Kasei Corporation (ASAA MU) stock market data APIs
€6.9712
-0.06(-0.9%)
as of November 18, 2025
Try our APIs with
free plan!
Asahi Kasei Corporation Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ASAA.MU.
Prev. Close
6.9712
Open
6.909
High
6.909
Low
6.9712
52 wk Range
5.5034-7.2003
Market Cap
11 940 M
Dividends (Yield)
2.8346
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Asahi Kasei Corporation data using free add-ons & libraries
Get Asahi Kasei Corporation Fundamental Data
Asahi Kasei Corporation Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 19.69
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Asahi Kasei Corporation News
New
Asahi Kasei Wins BioTech Breakthrough Award for Planova™ FG1 Filter
Planova FG1 Filter CHELMSFORD, Mass. & TOKYO, November 13, 2025--(BUSINESS WIRE)--Asahi Kasei Corporation has earned top honors in the 2025 BioTech Breakthrough Awards, winning the Biomanufacturing I...
Asahi Kasei Microdevices Showcases AgeTech and PetTech Solutions Combining Privacy and Convenience at CES® 2026
Mockup of Asahi Kasei Microdevices' booth at CES 2026, focusing on AgeTech and PetTech Sensing technologies enhance the health and safety of people and pets TOKYO, November 12, 2025--(BUSINESS WIRE)...
Calliditas Therapeutics Reports Safety Data for Setanaxib in Patients with Alport Syndrome at the American Society of Nephrology Kidney Week
STOCKHOLM, Nov. 10, 2025 /PRNewswire/ -- Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that primary safety endpoints of a Phase 2a, randomized, double-blind, placebo-co...
Asahi Kasei (TSE:3407) Margin Gains Reinforce Bullish Narratives After Five-Year Earnings Decline Reversal
Asahi Kasei (TSE:3407) reported net profit margins of 4%, up from 2.4% last year. Earnings growth over the past year reached a stellar 76.6%. Looking ahead, management is guiding for 13.28% earnings g...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
